Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Add To Watchlist

Bullboard (TSX:GUD)

View:

Comment by EbbFlow88on Apr 11, 2024 8:54am

RE:Antibe

They had a loan of $500,000 that was converted into shares. From the annual information form... "On March 27, 2018, Knight converted the debt into 2,489,889 Common Shares."

Discussion

Post by NSMTL05on Apr 10, 2024 8:49pm

Antibe

Anyone know if GUD had investments with Antibe, debt or equity? Thanks

131

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

(0)
•••

Post by PressReleaseon Apr 09, 2024 7:30am

New Press Release - Knight to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference

MONTREAL, April 09, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-US) specialty pharmaceutical company, announced today that Samira Sakhia, President and Chief Executive Officer, is scheduled to present a corporate update at the Bloom Burton &...read article.

(0)
•••

Post by PressReleaseon Mar 28, 2024 11:04am

New Press Release - Knight Therapeutics Inc. ranks on The Globe and Mail's fifth-annual Women Lead Here benchmark of executive gender diversity

MONTREAL, March 28, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”) is pleased to announce it will be recognized on The Globe and Mail’s 2024 Report on Business magazine’s fifth annual Women Lead Here list. This annual editorial benchmark identifies top...read article.

Post by wofatson Mar 25, 2024 11:47pm

Again? Is it support or faith?

Increasing position Filed 2024-03-25 13:55 Tx date 2024-03-25 $GUD Knight Therapeutics Inc. Armoyan, Sime ...more

209

Discussion

Post by GoldenInvestoron Mar 25, 2024 11:54am

418k+ shares traded!

Comment by longrun86on Mar 21, 2024 5:58pm

RE:RE:RE:RE:New Press Release - Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results

Q4 was gross and the 2024 Guidance was underwhelming. The impairment bothers me a bit but I also understand that currency issue. I haven't listened to the conference call recording but will this ...more

194

Discussion

Comment by wofatson Mar 21, 2024 11:36am

RE:RE:New Press Release - Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results

You said everything is bad This? Revenues were $328,199, an increase of $34,636 or 12% over prior year. Revenues excluding IAS 29 were $343,138, an increase of $51,368 or 18% over ...more

152

Discussion

(0)
•••

Post by PressReleaseon Mar 21, 2024 7:30am

New Press Release - Knight Therapeutics Reports Fourth Quarter and Year-End 2023 Results

Achieved Record Annual Revenues and EBITDA MONTREAL, March 21, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter and year ended...read article.

Post by Stockcadmanon Mar 20, 2024 6:42pm

Earnings

Let's see if they can show us a bit of growth for 2024. The stock is so depressed here trading at 5x EV/EBITDA.

Comment by longrun86on Mar 19, 2024 6:52pm

RE:Next Earnings - 2024/03/21

The fun begins! I am expecting that some fairly material insights into FY2024 and especially regarding the revenue and operating margin growth. I am also hopeful that they will be able to ...more

138

Discussion

Post by Sinisteron Mar 19, 2024 4:05pm

Next Earnings - 2024/03/21

So my fellow investors, what is your prediction and thoughts on the next earning? (Just for fun) I preddict that it wont change that much. What will really change the price is when those medication ...more

151

Discussion

Post by GoldenInvestoron Mar 15, 2024 10:58am

Morgan Stanley CIO on AI & drug discovery

Morgan Stanley CIO on CNBC speaking to how AI can help benefit healthcare via drug discovery. Once drugs are discovered, then they have to be produced. With 3 manufacturing ...more

129

Comment by wofatson Mar 14, 2024 10:27pm

RE:purchase one week out from results

Maybe they are covering some short positions. There is over 3 million. Makes money both ways.

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:GUD)